Machine learning-based risk model using 123 I-metaiodobenzylguanidine to differentially predict modes of cardiac death in heart failure
ConclusionA risk model based on machine learning using clinical variables and123I-MIBG differentially predicted ArE and HFD as causes of cardiac death.
Source: Journal of Nuclear Cardiology - Category: Nuclear Medicine Source Type: research
More News: Cardiology | Heart | Heart Failure | Learning | Nuclear Medicine | Reflex Sympathetic Dystrophy | Universities & Medical Training